Last reviewed · How we verify

Tramadol hydrochloride/Acetaminophen Tab.

Daewon Pharmaceutical Co., Ltd. · Phase 3 active Small molecule

Tramadol inhibits norepinephrine and serotonin reuptake while acting as a weak opioid agonist, and acetaminophen reduces pain through central analgesic and antipyretic effects.

Tramadol inhibits norepinephrine and serotonin reuptake while acting as a weak opioid agonist, and acetaminophen reduces pain through central analgesic and antipyretic effects. Used for Moderate to moderately severe acute pain.

At a glance

Generic nameTramadol hydrochloride/Acetaminophen Tab.
SponsorDaewon Pharmaceutical Co., Ltd.
Drug classOpioid analgesic combination
TargetMu-opioid receptor; norepinephrine transporter; serotonin transporter
ModalitySmall molecule
Therapeutic areaPain Management
PhasePhase 3

Mechanism of action

Tramadol is a synthetic opioid that works through dual mechanisms: it binds to mu-opioid receptors and inhibits the reuptake of norepinephrine and serotonin in the central nervous system, enhancing pain modulation. Acetaminophen complements this by inhibiting prostaglandin synthesis in the CNS, providing additional analgesic and antipyretic activity. The combination provides enhanced pain relief for moderate to moderately severe pain.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: